NCT04142359View on ClinicalTrials.gov

PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)

TerminatedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

December 9, 2019

Primary Completion Date

April 6, 2020

Study Completion Date

April 6, 2020

Conditions
Pharmacokinetics
Interventions
BIOLOGICAL

BCG in Combination with N-803

BCG in Combination with N-803

DRUG

N-803 alone

N-803 alone

Trial Locations (6)

10016

Manhattan Medical Research, New York

11530

NYU Winthrop University Hospital Department of Urology, Garden City

23235

Virginia Urology, Richmond

33136

University of Miami Miller School of Medicine-Sylvester Comprehensive Cancer Center, Miami

68114

Adult & Pediatric Urology, Omaha

90024

UCLA Department of Urology, Los Angeles

Sponsors

Lead Sponsor

Altor BioScience
All Listed Sponsors
lead

Altor BioScience

INDUSTRY

NCT04142359 - PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14) | Biotech Hunter | Biotech Hunter